ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,173Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 245

$1.28M Total Retail Price of All Prescriptions

Rank: 17 out of 245

708 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 708 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 708 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 3,691 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$178 was the average price of a prescription from this provider, compared to $230 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
GABAPENTIN 433 211 1 1
DONEPEZIL HCL 402 367 2 3
LEVETIRACETAM 316 116 3 4
HYDROCODONE-ACETAMINOPHEN 309 75 S3 4 7
NAMENDA 246 230 5 5
CARBIDOPA-LEVODOPA 246 232 5 2
TIZANIDINE HCL 195 71 7 13
BACLOFEN 162 48 8 12
LYRICA 143 73 9 11
TOPIRAMATE 141 13 10 6
PRIMIDONE 128 77 11 9
CYMBALTA 126 55 12 14
LAMOTRIGINE 124 44 13 8
CLOPIDOGREL 122 73 14 43
AMITRIPTYLINE HCL 116 53 R 15 15
DILANTIN 113 22 16 28
PHENYTOIN SODIUM EXTENDED 104 26 17 25
TRAMADOL HCL 97 66 18 21
MIRTAZAPINE 91 42 19 48
PRAMIPEXOLE DIHYDROCHLORIDE 90 79 20 16
OXYCODONE-ACETAMINOPHEN 87 54 S2 21 49
OXYCODONE HCL-ACETAMINOPHEN 82 26 S2 22 35
PLAVIX 76 56 23 59
QUETIAPINE FUMARATE 73 51 24 36
COPAXONE 71 33 25 30
TRAZODONE HCL 66 55 26 27
CITALOPRAM HBR 65 38 27 18
ESCITALOPRAM OXALATE 65 20 27 85
TEGRETOL 64 0 29 113
CARBAMAZEPINE 62 14 30 33
DIVALPROEX SODIUM 59 18 31 47
DIVALPROEX SODIUM ER 57 14 32 19
ZOLPIDEM TARTRATE 56 14 33 17
AGGRENOX 54 53 34 67
CARBATROL 53 0 35 97
CYCLOBENZAPRINE HCL 53 18 R 35 38
FENTANYL 52 37 S2 37 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 3, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.